Index of reports
> Cases with Neoplasm Progression (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Etodolac where reactions include neoplasm progression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Etodolac side effects in male
Reported by a physician from Japan on 2012-08-23
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Renal Impairment, C-Reactive Protein Increased, Neoplasm Malignant, Neoplasm Progression, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2012-01-06
End date: 2012-01-09
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-12-14
End date: 2011-12-29
Afinitor
Dosage: 10 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-20
End date: 2011-10-03
Etodolac
Dosage: 400 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Prednisolone
Dosage: 5 mg
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-21
End date: 2011-09-01
Zometa
Dosage: unk ukn, unk
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-27
Other drugs received by patient: Allopurinol; Benidipine Hydrochloride; Vitamin B12; Limaprost Alfadex; Lansoprazole; Limaprost Alfadex; Flivas; Acetaminophen
Possible Etodolac side effects in male
Reported by a physician from Japan on 2012-07-02
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Death, Renal Impairment, Neoplasm Malignant, C-Reactive Protein Increased, Neoplasm Progression, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 10 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-20
End date: 2011-10-03
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-12-14
End date: 2011-12-29
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2012-01-06
End date: 2012-01-09
Etodolac
Dosage: 400 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Prednisolone Sodium Succinate INJ
Dosage: 5 mg
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-21
End date: 2011-09-01
Zometa
Dosage: unk ukn, unk
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-27
Other drugs received by patient: Lansoprazole; Limaprost Alfadex; Flivastatin Sodium; Allopurinol; Vitamin B12; Limaprost Alfadex; Benidipine Hydrochloride; Acetaminophen
Possible Etodolac side effects in 77 year old male
Reported by a pharmacist from Japan on 2012-04-05
Patient: 77 year old male
Reactions: Neoplasm Malignant, Drug Interaction, Neoplasm Progression, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etodolac
Other drugs received by patient possibly interacting with the suspect drug: Lyrica
Dosage: 150mg, daily
Administration route: Oral
Indication: Cancer Pain
Start date: 2011-02-15
End date: 2011-02-28
Morphine Sulfate
Dosage: 30mg, daily
Administration route: Oral
Indication: Cancer Pain
Start date: 2010-01-11
Possible Etodolac side effects in male
Reported by a physician from Japan on 2012-03-15
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Renal Impairment, Neoplasm Malignant, C-Reactive Protein Increased, Neoplasm Progression, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 10 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-20
End date: 2011-10-03
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-12-14
End date: 2011-12-29
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2012-01-06
End date: 2012-01-09
Etodolac
Dosage: 400 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Prednisolone
Dosage: 5 mg
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-21
End date: 2011-09-01
Zometa
Dosage: unk ukn, unk
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-27
Other drugs received by patient: Allopurinol; Benidipine Hydrochloride; Acetaminophen; Lansoprazole; Limaprost Alfadex; Methycobal; Flivas; Limaprost Alfadex
|